Skip to main content
. 2021 Sep 9;11:17951. doi: 10.1038/s41598-021-97559-y

Table 1.

The drug susceptibility test was used as a standard method to evaluate the efficacy of the DNA microarray for detecting RIF and INH resistance and MDR-TB.

CapitalBio DNA microarray DST (n = 4148) Sensitivity (%) Specificity (%) AR (%) PPV (%) NPV (%) k
R S
RIF
Overall
R 228 92 81.4 97.6 96.5 71.3 98.6 0.74
S 52 3776
 ≤ AFB 1 + 
R 53 32 72.6 97.7 96.5 62.4 98.6 0.65
S 20 1399
AFB 2 + 
R 85 36 84.2 95.0 93.7 70.3 97.7 0.73
S 16 690
AFB 3 + 
R 44 13 84.6 98.2 97.2 77.2 99.2 0.79
S 8 695
AFB 4 + 
R 46 11 85.2 98.9 98.2 80.7 99.1 0.82
S 8 992
INH
Overall
R 324 108 74.0 97.1 94.7 75.0 96.9 0.72
S 114 3602
 ≤ AFB 1 + 
R 113 40 67.3 97.0 93.7 73.9 95.9 0.67
S 55 1296
AFB 2 + 
R 80 25 74.8 96.5 93.7 76.2 96.3 0.72
S 27 695
AFB 3 + 
R 55 22 76.4 96.8 94.9 71.4 97.5 0.71
S 17 666
AFB 4 + 
R 76 21 83.5 97.8 96.6 78.4 98.4 0.79
S 15 945
MDR-TB
Overall
R 141 39 69.8 99.0 97.6 78.3 98.5 0.73
S 61 3907
 ≤ AFB 1 + 
R 36 14 60.0 99.0 97.5 72.0 98.4 0.64
S 24 1430
AFB 2 + 
R 39 14 70.9 98.2 96.4 73.6 97.9 0.70
S 16 758
AFB 3 + 
R 31 8 73.8 98.9 97.5 79.5 98.5 0.75
S 11 710
AFB 4 + 
R 35 3 77.8 99.7 98.8 92.1 99.0 0.84
S 10 1009

DST drug sensitivity test, R resistant, S susceptible, AR agreement rate, PPV positive predictive value, NPV negative predictive value, AFB acid-fast bacilli.